Cracow

• ROLLOVER STUDY FOR TAZEMETOSTAT Ended
  2023-510553-41-00 9 2016-08-29 Subjects will receive tazemetostat as dictated in their antecedent stu
• autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea … Ended
  2024-511235-10-00 5 2016-07-25 Generalized mantle cell Lymphoma
• A study of nivolumab or placebo in patients following removal of their esophageal or gastroesophageal junction cancer. Ended
  2023-509360-24-00 5 2016-06-16 Subjects with resected adenocarcinoma or squamous cell carcinoma esoph
• A Multi-Center, Open-Label Study of Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Ped … Ended
  2023-504711-32-00 5 2015-11-24 Ulcerative Colitis
• The purpose of this study is to determine whether long-term RPC1063 is safe and effective in the treatment of ulcerative colitis (UC) Ended
  2024-514815-92-00 5 2015-07-16 Ulcerative colitis
• A Trial to See the Effects of ACP-196 (the test drug) in Patients who have Mantle Cell Lymphoma Ended
  2023-509352-34-00 4 2015-06-18 Mantle Cell Lymphoma
• A Long-Term, Open-Label, Study for Treatment of JIA Ended
  2023-509651-14-00 10 2013-04-03 Juvenile Idiopathic Arthritis (JIA)
• Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma Ended
  2023-506419-16-00 5 2013-01-08 Advanced Classical Hodgkin Lymphoma
• EQU-001 as an Add-On Drug for People with Focal Seizures while on Medication Ended
  2022-500302-18-00 4 Epilepsy
• A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended
  2022-501353-37-00 5 Reversal of anticoagulation effect in patients on a FXa inhibitor (api
• A Phase 2 Study of BMS-986315 and Nivolumab in Combination with Chemotherapy in Participants with First-line Stage IV or Recurrent NSCLC Ended
  2022-503007-22-00 4 Non-small Cell Lung Cancer
• Study of Obeldesivir in Children and Adolescents With COVID-19 Ended
  2023-503282-27-00 10 COVID-19
• Study of IMG-007 in Participants with Moderate to Severe Atopic Dermatitis Ended
  2023-505735-13-01 9 Atopic dermatitis
• Efficacy and safety of the proposed biosimilar PERT-IJS versus EU-Perjeta® along with trastuzumab and chemotherapy (carboplatin and docetaxe … Ended
  2023-506163-34-00 5 Hormone Receptor Negative (HR-ve) Human Epidermal Growth Factor Recept
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan … Ended
  2023-506487-13-00 5 Hormone receptor-positive, her2-negative advanced/metastatic breast ca
• MK-1200 for Advanced Solid Tumors Ended
  2023-508684-68-00 9 Advanced solid tumor
• A clinical study comparing different doses of a potential new medicine with an inactive medicine for patients with moderate to severe psoria … Ended
  2023-508992-35-00 4 Plaque Psoriasis
• A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneratio … Ended
  2023-509206-29-00 5 Neovascular age-related macular degeneration (nAMD)
• A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and … Ended
  2024-512417-41-00 5 Osteoporosis
• A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONS … Ended
  2024-512804-20-00 5 Metastatic Colorectal Cancer
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart i … Ended
  2024-512986-15-00 4 Sjögren’s Disease
• CHRONOS - A study to learn about the effects and safety of ODM-111 in participants with long-lasting pain due to osteoarthritis of the knee. Ended
  2024-513553-79-00 4 Chronic Pain due to Ostheoarthritis of the knee
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain ( TRIUMPH-7 ) Ended
  2024-517431-43-00 5 Overweight
• A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of iN1011-N17-02 in Patients with Post herpetic Neur … Ended
  2024-518747-38-00 4 Post herpetic Neuralgia

Showing 1,057–1,080 of 1,081 trials